Agency Information Collection Activities; Comment Request; Pharmacy Billing Requirement
Notice of availability; request for comments.
Citation: "87 FR 22951"
Page Number: "22951"
"Notices"
SUMMARY:
DATES: Consideration will be given to all written comments received
ADDRESSES: A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained free by contacting
Submit written comments about, or requests for a copy of, this ICR by mail or courier to the
FOR FURTHER INFORMATION: Contact
SUPPLEMENTARY INFORMATION: The DOL, as part of continuing efforts to reduce paperwork and respondent burden, conducts a pre-clearance consultation program to provide the general public and Federal agencies an opportunity to comment on proposed and/or continuing collections of information before submitting them to the OMB for final approval. This program helps to ensure requested data can be provided in the desired format, reporting burden (time and financial resources) is minimized, collection instruments are clearly understood, and the impact of collection requirements can be properly assessed.
This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless it is approved by the OMB under the PRA and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information that does not display a valid Control Number. See 5 CFR 1320.5(a) and 1320.6.
Interested parties are encouraged to provide comments to the contact shown in the ADDRESSES section. Comments must be written to receive consideration, and they will be summarized and included in the request for OMB approval of the final ICR. In order to help ensure appropriate consideration, comments should mention 1240-0050.
Submitted comments will also be a matter of public record for this ICR and posted on the internet, without redaction. The DOL encourages commenters not to include personally identifiable information, confidential business data, or other sensitive statements/information in any comments.
The DOL is particularly interested in comments that:
* Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
* Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
* Enhance the quality, utility, and clarity of the information to be collected; and
* Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses.
Agency: DOL-OWCP.
Type of Review: Extension.
Title of Collection: Pharmacy Billing Requirements.
OMB Control Number: 1240-0050.
Affected Public: Individuals or households.
Estimated Number of Respondents: 874,414.
Frequency: Annually.
Total Estimated Annual Responses: 874,414.
Estimated Average Time per Response: 1 minute.
Estimated Total Annual
Total Estimated Annual Other Cost Burden:
Authority: 44 U.S.C. 3506(c)(2)(A).
Agency Clearance Officer.
[FR Doc. 2022-08224 Filed 4-15-22;
BILLING CODE 4510-CR-P
AM Best Assigns Credit Ratings to Manufacturing Technology Mutual Insurance Company
Biden Proposes ‘Billionaire’s Minimum Income Tax’ As Poll Numbers Fall
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News